KD Logo

Recent Insider Activity Suggests Potential Gains for Pacira BioSciences Inc (PCRX)

Pacira BioSciences Inc’s recently made public that its Director PACE GARY W unloaded Company’s shares for reported $2.75 million on Mar 08 ’24. In the deal valued at $30.60 per share,90,000 shares were sold. As a result of this transaction, PACE GARY W now holds 22,127 shares worth roughly $0.67 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, PACE GARY W sold 28,257 shares, generating $870,598 in total proceeds. Upon selling the shares at $30.81, the Director now owns 112,127 shares.

Before that, PACE GARY W sold 1,066 shares. Pacira BioSciences Inc shares valued at $31,628 were divested by the Director at a price of $29.67 per share. As a result of the transaction, PACE GARY W now holds 140,384 shares, worth roughly $4.26 million.

A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. TD Cowen also remained covering PCRX and has increased its forecast on August 03, 2023 with a “an Outperform” recommendation from previously “Market perform” rating.

Price Performance Review of PCRX

On Monday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock jump 3.26% to $30.38. Over the last five days, the stock has gained 14.64%. Pacira BioSciences Inc shares have fallen nearly -9.96% since the year began. Nevertheless, the stocks have fallen -27.70% over the past one year. While a 52-week high of $42.96 was reached on 01/08/24, a 52-week low of $25.33 was recorded on 04/26/24. SMA at 50 days reached $28.31, while 200 days put it at $30.83. A total of 1.24 million shares were traded, compared to the trading of 5.64 million shares in the previous session.

Levels Of Support And Resistance For PCRX Stock

The 24-hour chart illustrates a support level at 29.84, which if violated will result in even more drops to 29.30. On the upside, there is a resistance level at 30.87. A further resistance level may holdings at 31.36. The Relative Strength Index (RSI) on the 14-day chart is 66.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.47, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 8.01%. Stochastics %K at 84.76% indicates the stock is a selling.

Most Popular